Author-it Software Corporation (ASC), focused on component authoring solutions, and EndPoint Technologies, a specialty consulting firm focused on Medical Affairs in the life science industry, have formed a strategic partnership to expand the availability and utilization of component authoring technology in the pharmaceutical and biotech industries.
“The industry struggles with disjointed systems, inefficiencies, human errors, low visibility and the high costs of managing the lifecycle of medical, clinical and regulatory information,” said Brian Nace, sr. vice president, Client Success and Sales at Author-it. “Instead of managing documents containing untold amounts of replicated information, what if you could manage the information itself as discrete components? That’s the vision of reusable component authoring. With Author-it’s vision of creating a platform of reusable components for Life Sciences, EndPoint will prove to be a key partner as they have the experience, comprehensive technology and business consulting services in the Medical Affairs industry. Author-it is pleased to be partnering with EndPoint’s industry experts to create a strategic direction for reusable component authoring in life science organizations.”
Joe Pierce, founder of EndPoint, stated, “While EndPoint has extensive experience in medical information solutions and broad relationships in the industry, Author-it has a unique and valuable solution solving a very real problem in content management. EndPoint looks for not only new technology solutions to add to our portfolio, but solutions that provide real value and return on investment for our clients. EndPoint is excited to be working with Author-it to greatly expand the exposure and utilization of this necessary technology.”
The medical information business process requires the creation, management and significant use of medical content in many forms. ASC technology enables the efficient authoring, sharing and reuse of information across several content types. Reuse of information drives massive process and content production improvements including increased productivity, reduced time to market, better accuracy and consistency, improved customer experience and substantial cost savings. The timely, strategic partnership with EndPoint—whose experience and expertise in Medical Affairs information technology gives them intimate knowledge of that industry’s unique needs—will open new avenues and applications for ASC’s component authoring technology, and new solutions for EndPoint’s global pharmaceutical and biotech clients.
